RETA Historical Earnings image   This RETA historical earnings page last updated 11/10/2022
RETA Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/8/20220.00B
Q2 20228/8/20220.00B
Q1 20225/10/20220.00B
Q4 20212/28/20220.00B
Q3 202111/8/20210.01B
Q2 20218/9/20210.00B
Q1 20215/6/20210.00B
Q4 20203/1/20210.00B
Q3 202011/9/20200.00B
Q2 20208/10/20200.00B
Q1 20205/11/20200.00B
Q4 20192/19/20200.00B
Q3 201911/12/20190.01B
Q2 20198/8/20190.01B
Q1 20195/9/20190.01B
Q4 20182/28/20198.45M
Q3 201811/7/20185.17M
Q2 20188/8/20187.57M
Q1 20185/8/201832.39M
Q4 20173/2/20189.96M
Q3 201711/13/201712.56M
Q2 20178/14/201712.81M
Q1 20175/11/201712.73M
Q4 20163/3/201712.50M
Q3 201611/14/201612.55M
Q2 20168/11/201612.37M
RETA Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q3 202211/8/2022-1.470
Q2 20228/8/2022-1.360
Q1 20225/10/2022-1.330
Q4 20212/28/2022-1.590
Q3 202111/8/2021-1.270
Q2 20218/9/2021-1.320
Q1 20215/6/2021-1.160
Q4 20203/1/2021-1.250
Q3 202011/9/2020-1.310
Q2 20208/10/2020-1.230
Q1 20205/11/2020-1.470
Q4 20192/19/2020-1.590
Q3 201911/12/2019-1.320
Q2 20198/8/2019-1.140
Q1 20195/9/2019-0.980
Q4 20182/28/2019-0.86
Q3 201811/7/2018-1.07
Q2 20188/8/2018-1.08
Q1 20185/8/20180.15
Q4 20173/2/2018-0.64
Q3 201711/13/2017-0.5
Q2 20178/14/2017-0.52
Q1 20175/11/2017-0.32
Q4 20163/3/2017-0.19
Q3 201611/14/2016-0.04
Q2 20168/11/2016-0.05
Quotes delayed 20 minutes

Email EnvelopeFree RETA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Reata Pharmaceuticals (RETA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

RGEN Historical Earnings
RGLS Historical Earnings
RGNX Historical Earnings
RIGL Historical Earnings
RLAY Historical Earnings
RLMD Historical Earnings
RLYB Historical Earnings
RMD Historical Earnings
RMED Historical Earnings
RMTI Historical Earnings
What was the record high RETA historical earnings result?
In terms of earnings or revenue, what is the best RETA historical earnings result that Reata Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest RETA historical earnings result was set in Q1 2018, when Reata Pharmaceuticals posted results of 0.15/share. The most successful revenue quarter within our data set was Q1 2018 when Reata Pharmaceuticals reported revenue of 32.39M.

What was the lowest Reata Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest RETA has reported, and when?

✔️Accepted answer: Within our data set, the lowest RETA historical earnings result was set in Q4 2021, when Reata Pharmaceuticals posted results of -1.590/share. The smallest revenue quarter within our data set was Q3 2022 when Reata Pharmaceuticals reported revenue of 0.00B.

On this page we presented the RETA historical earnings date information for Reata Pharmaceuticals. Reviewing that RETA Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2018, when RETA posted adjusted EPS of 0.15/share. Meanwhile the lowest RETA historical earnings result was in Q4 2021, when RETA posted adjusted EPS of -1.590/share. Moving to Reata Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2018 when RETA reported 32.39M in revenue, while the smallest revenue quarter was Q3 2022 when RETA reported 0.00B in revenue.

For self directed investors doing their due diligence on RETA or any other given stock, their research can benefit from looking into all of the Reata Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Reata Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for RETA. Thanks for visiting, and the next time you need to research RETA historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Intuit MACD, Institutional Holders of NUGT, Top Ten Hedge Funds Holding LB.

 

RETA Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.